A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and efficacy of Eperisone in Amyotrophic Lateral Sclerosis - EPERISONE AND ALS A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and effica ...
A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and efficacy of Eperisone in Amyotrophic Lateral Sclerosis - EPERISONE AND ALS A pilot, prospective, randomized, open, blinded end point, phase II study of tolerability and effica ...